The pharmaceutical industry is poised for robust growth, fueled by a rapidly expanding medicinal drug and vaccine market. Due to the persistent necessity of its products, the industry retains stability, which makes it less vulnerable to economic fluctuations.
Given this backdrop, quality pharma stocks Neurocrine Biosciences, Inc. (NBIX), AbbVie Inc. (ABBV), and Novo Nordisk A/S (NVO), with an overall rating of A (Strong Buy) in our proprietary POWR Ratings system, could be solid buys now.
